ACTL6B
Actin-like protein 6B
Also known as: ACL6B_HUMAN, ACTL6, BAF53B, SMARCN2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94805
- Gene
- ACTL6B
- Ensembl
- ENSG00000077080
- Chromosome
- 7
- Canonical length
- 426 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoli rim,Mitotic chromosome
OverviewNCBI Gene
The protein encoded by this gene is a member of a family of actin-related proteins (ARPs) which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common feature. The ARPs are involved in diverse cellular processes, including vesicular transport, spindle orientation, nuclear migration and chromatin remodeling. This gene encodes a subunit of the BAF (BRG1/brm-associated factor) complex in mammals, which is functionally related to SWI/SNF complex in S. cerevisiae and Drosophila; the latter is thought to facilitate transcriptional activation of specific genes by antagonizing chromatin-mediated transcriptional repression. This subunit may be involved in the regulation of genes by structural modulation of their chromatin, specifically in the brain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
426 residues, UniProt reviewed canonical sequence.
>O94805|ACTL6B
1 MSGGVYGGDE VGALVFDIGS FSVRAGYAGE DCPKADFPTT VGLLAAEEGG GLELEGDKEK
61 KGKIFHIDTN ALHVPRDGAE VMSPLKNGMI EDWECFRAIL DHTYSKHVKS EPNLHPVLMS
121 EAPWNTRAKR EKLTELMFEQ YNIPAFFLCK TAVLTAFANG RSTGLVLDSG ATHTTAIPVH
181 DGYVLQQGIV KSPLAGDFIS MQCRELFQEM AIDIIPPYMI AAKEPVREGA PPNWKKKEKL
241 PQVSKSWHNY MCNEVIQDFQ ASVLQVSDSP YDEQVAAQMP TVHYEMPNGY NTDYGAERLR
301 IPEGLFDPSN VKGLSGNTML GVGHVVTTSI GMCDIDIRPG LYGSVIVTGG NTLLQGFTDR
361 LNRELSQKTP PSMRLKLIAS NSTMERKFSP WIGGSILASL GTFQQMWISK QEYEEGGKQC
421 VERKCPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACTL6B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 51 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 51 nTPM
- cerebral cortex: 40 nTPM
- basal ganglia: 33 nTPM
- hypothalamus: 19 nTPM
- hippocampal formation: 19 nTPM
- amygdala: 18 nTPM
Single-cell type
- retinal ganglion cells: 43 nCPM
- retinal amacrine cells: 40 nCPM
- brain excitatory neurons: 39 nCPM
- gonadotrophs: 38 nCPM
- brain inhibitory neurons: 36 nCPM
- retinal horizontal cells: 34 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 57 nTPM
- basal ganglia: 42 nTPM
- white matter: 37 nTPM
- cerebellum: 32 nTPM
- hippocampal formation: 32 nTPM
- hypothalamus: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACTL6B.
Disease | AllUniProt
Conditions ACTL6B is implicated in, by any mechanism.
- Developmental and epileptic encephalopathy 76 (DEE76) MIM:618468
- Intellectual developmental disorder with severe speech and ambulation defects (IDDSSAD) MIM:618470
Disease | GeneticClinVar
54 pathogenic / likely-pathogenic of 165 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 76
- ACTL6B-related recessive epilepsy
- Intellectual developmental disorder with severe speech and ambulation defects
- Autism spectrum disorder
- Intellectual disability
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 3.27
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin organization
- chromatin remodeling
- dendrite development
- negative regulation of cell differentiation
- nervous system development
- neuron maturation
- positive regulation of cell differentiation
- positive regulation of cell population proliferation
- positive regulation of double-strand break repair
- positive regulation of myoblast differentiation
- positive regulation of stem cell population maintenance
- positive regulation of T cell differentiation
- regulation of G0 to G1 transition
- regulation of G1/S transition of mitotic cell cycle
- regulation of mitotic metaphase/anaphase transition
- regulation of nucleotide-excision repair
- regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACTL6B as an antibody target. Whether an autoantibody or antibody against ACTL6B could matter depends on whether native ACTL6B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACTL6B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACTL6B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...